{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T21:54:52Z","timestamp":1781906092107,"version":"3.54.5"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.steroids.2024.109489","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T23:31:54Z","timestamp":1722987114000},"page":"109489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Rodent models in polycystic ovarian syndrome: Dissecting reproductive and metabolic phenotypes for therapeutic advancements"],"prefix":"10.1016","volume":"211","author":[{"given":"Smarto","family":"Basak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Kumar Dixit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjit","family":"Kumar Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susmita","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvathy G","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gajji","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2024.109489_b0005","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic Ovary Syndrome","volume":"333","author":"Franks","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.steroids.2024.109489_b0010","first-page":"100524","volume":"21","year":"2022","journal-title":"Health - Eur."},{"key":"10.1016\/j.steroids.2024.109489_b0015","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2265.2010.03956.x","article-title":"research in polycystic ovary syndrome today and tomorrow","volume":"74","author":"Pasquali","year":"2011","journal-title":"Clin. Endocrinol. (oxf.)"},{"key":"10.1016\/j.steroids.2024.109489_b0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.steroids.2024.109489_b0025","doi-asserted-by":"crossref","unstructured":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS), Hum. Reprod. 19 (2004) 41\u201347. https:\/\/doi.org\/10.1093\/humrep\/deh098.","DOI":"10.1093\/humrep\/deh098"},{"key":"10.1016\/j.steroids.2024.109489_b0030","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.steroids.2024.109489_b0035","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/ncpendmet0637","article-title":"The reproductive phenotype in polycystic ovary syndrome","volume":"3","author":"Chang","year":"2007","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"key":"10.1016\/j.steroids.2024.109489_b0040","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ando.2010.02.007","article-title":"Aberrant follicle development and anovulation in polycystic ovary syndrome","volume":"71","author":"Franks","year":"2010","journal-title":"Ann. Endocrinol."},{"key":"10.1016\/j.steroids.2024.109489_b0045","doi-asserted-by":"crossref","first-page":"E801","DOI":"10.1152\/ajpendo.00107.2005","article-title":"Postnatal developmental consequences of altered insulin sensitivity in female sheep treated prenatally with testosterone","volume":"289","author":"Recabarren","year":"2005","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"key":"10.1016\/j.steroids.2024.109489_b0050","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1620\/tjem.140.121","article-title":"Endocrinological and histological aspects of the process of polycystic ovary formation in the rat treated with testosterone propionate","volume":"140","author":"Ota","year":"1983","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.steroids.2024.109489_b0055","first-page":"7754","article-title":"Transcutaneous electrical acupoint stimulation alleviates the hyperandrogenism of polycystic ovarian syndrome rats by regulating the expression of P450arom and CTGF in the ovaries","volume":"8","author":"Qu","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.steroids.2024.109489_b0060","doi-asserted-by":"crossref","first-page":"e0196862","DOI":"10.1371\/journal.pone.0196862","article-title":"Elevated androstenedione in young adult but not early adolescent prenatally androgenized female rats","volume":"13","author":"Shah","year":"2018","journal-title":"PLOS ONE"},{"key":"10.1016\/j.steroids.2024.109489_b0065","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1113\/expphysiol.2014.078055","article-title":"Introducing a rat model of prenatal androgen-induced polycystic ovary syndrome in adulthood","volume":"99","author":"Tehrani","year":"2014","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.steroids.2024.109489_b0070","doi-asserted-by":"crossref","first-page":"e99155","DOI":"10.1371\/journal.pone.0099155","article-title":"The Characterization of Obese Polycystic Ovary Syndrome Rat Model Suitable for Exercise Intervention","volume":"9","author":"Wu","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.steroids.2024.109489_b0075","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1210\/en.2012-1105","article-title":"Angiopoietins\/TIE2 System and VEGF Are Involved in Ovarian Function in a DHEA Rat Model of Polycystic Ovary Syndrome","volume":"153","author":"Abramovich","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2024.109489_b0080","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.3892\/ol.2015.3466","article-title":"Bak Foong pills combined with metformin in the treatment of a polycystic ovarian syndrome rat model","volume":"10","author":"Liu","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.steroids.2024.109489_b0085","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1757-2215-5-15","article-title":"Polycystic ovary syndrome resembling histopathological alterations in ovaries from prenatal androgenized female rats","volume":"5","author":"Wang","year":"2012","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.steroids.2024.109489_b0090","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1210\/en.2014-1196","article-title":"Characterization of Reproductive, Metabolic, and Endocrine Features of Polycystic Ovary Syndrome in Female Hyperandrogenic Mouse Models","volume":"155","author":"Caldwell","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2024.109489_b0095","doi-asserted-by":"crossref","first-page":"e87623","DOI":"10.1371\/journal.pone.0087623","article-title":"Oriental Medicine Kyung-Ok-Ko Prevents and Alleviates Dehydroepiandrosterone-Induced Polycystic Ovarian Syndrome in Rats","volume":"9","author":"Jang","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.steroids.2024.109489_b0100","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13048-017-0375-7","article-title":"DHEA-induced ovarian hyperfibrosis is mediated by TGF-\u03b2 signaling pathway","volume":"11","author":"Wang","year":"2018","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.steroids.2024.109489_b0105","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3109\/09513590.2016.1163672","article-title":"Effects of chronic DHEA treatment on central and peripheral reproductive parameters, the onset of vaginal opening and the estrous cycle in female rats","volume":"32","author":"Iwasa","year":"2016","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.steroids.2024.109489_b0110","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1073\/pnas.1523236113","article-title":"Brown adipose tissue transplantation ameliorates polycystic ovary syndrome","volume":"113","author":"Yuan","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.steroids.2024.109489_b0115","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1210\/en.2012-1954","article-title":"Estradiol Negative and Positive Feedback in a Prenatal Androgen-Induced Mouse Model of Polycystic Ovarian Syndrome","volume":"154","author":"Moore","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2024.109489_b0120","doi-asserted-by":"crossref","DOI":"10.1210\/en.2016-1333","article-title":"Kisspeptin in the hypothalamus of two rat models of polycystic ovary syndrome","author":"Osuka","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2024.109489_b0125","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1507\/endocrj.K09E-205","article-title":"Endocrine Traits of Polycystic Ovary Syndrome in Prenatally Androgenized Female Sprague-Dawley Rats","volume":"57","author":"Wu","year":"2010","journal-title":"Endocr. J."},{"key":"10.1016\/j.steroids.2024.109489_b0130","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1210\/en.2007-0168","article-title":"A New Rat Model Exhibiting Both Ovarian and Metabolic Characteristics of Polycystic Ovary Syndrome","volume":"148","author":"Manner\u00e5s","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2024.109489_b0135","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1177\/1933719115570900","article-title":"Effects of Resveratrol on Ovarian Morphology, Plasma Anti-Mullerian Hormone, IGF-1 Levels, and Oxidative Stress Parameters in a Rat Model of Polycystic Ovary Syndrome","volume":"22","author":"Ergenoglu","year":"2015","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.steroids.2024.109489_b0140","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1095\/biolreprod35.3.647","article-title":"Development of the Polycystic Ovarian Condition (PCO) in the Estradiol Valerate-Treated Rat","volume":"35","author":"Brawer","year":"1986","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.steroids.2024.109489_b0145","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1477-7827-11-68","article-title":"Unilateral or bilateral vagotomy induces ovulation in both ovaries of rats with polycystic ovarian syndrome","volume":"11","author":"Linares","year":"2013","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.steroids.2024.109489_b0150","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13048-015-0203-x","article-title":"Does metformin improve in vitro maturation and ultrastructure of oocytes retrieved from estradiol valerate polycystic ovary syndrome-induced rats","volume":"8","author":"Mesbah","year":"2015","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.steroids.2024.109489_b0155","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1095\/biolreprod36.5.1229","article-title":"An Intractable, Ovary-Independent Impairment in Hypothalamo-Pituitary Function in the Estradiol-Valerate-Induced Polycystic Ovarian Condition in the Rat1","volume":"36","author":"Simard","year":"1987","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.steroids.2024.109489_b0160","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1590\/S1678-91992012000400006","article-title":"Bee venom treatment reduced C-reactive protein and improved follicle quality in a rat model of estradiol valerate-induced polycystic ovarian syndrome","volume":"18","author":"Karimzadeh","year":"2012","journal-title":"J. Venom. Anim. Toxins Trop. Dis."},{"key":"10.1016\/j.steroids.2024.109489_b0165","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s11011-016-9807-0","article-title":"Increase of kisspeptin-positive cells in the hypothalamus of a rat model of polycystic ovary syndrome","volume":"31","author":"Kondo","year":"2016","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.steroids.2024.109489_b0170","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/humrep\/dei399","article-title":"Aortic function is compromised in a rat model of polycystic ovary syndrome","volume":"21","author":"Lakhani","year":"2006","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.steroids.2024.109489_b0175","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s00018-013-1448-4","article-title":"Long-term incubation with mifepristone (MLTI) increases the spine density in developing Purkinje cells: new insights into progesterone receptor mechanisms","volume":"71","author":"Wessel","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.steroids.2024.109489_b0180","doi-asserted-by":"crossref","first-page":"e3145","DOI":"10.1038\/cddis.2017.494","article-title":"ANP promotes proliferation and inhibits apoptosis of ovarian granulosa cells by NPRA\/PGRMC1\/EGFR complex and improves ovary functions of PCOS rats","volume":"8","author":"Zheng","year":"2017","journal-title":"Cell Death Dis."},{"issue":"55","key":"10.1016\/j.steroids.2024.109489_b0185","first-page":"121","article-title":"Mode of action of medical methods of abortion","volume":"1972","author":"Baird","year":"2000","journal-title":"J. Am. Med. Womens Assoc."},{"key":"10.1016\/j.steroids.2024.109489_b0190","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/uog.6418","article-title":"Effect of mifepristone on the corpus luteum in early pregnancy","volume":"34","author":"Niinim\u00e4ki","year":"2009","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.steroids.2024.109489_b0195","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.contraception.2011.04.008","article-title":"A randomized study of the effect of mifepristone alone or in conjunction with ethinyl estradiol on ovarian function in women using the etonogestrel-releasing subdermal implant, Implanon\u00ae","volume":"84","author":"Weisberg","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.steroids.2024.109489_b0200","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.arcmed.2006.04.006","article-title":"Microscopic Characterization of Follicular Structures in Letrozole-induced Polycystic Ovarian Syndrome in the Rat","volume":"37","author":"Baravalle","year":"2006","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.steroids.2024.109489_b0205","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.arcmed.2003.10.005","article-title":"Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease","volume":"35","author":"Kafali","year":"2004","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.steroids.2024.109489_b0210","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1210\/en.2015-1733","article-title":"A Dietary Medium-Chain Fatty Acid, Decanoic Acid, Inhibits Recruitment of Nur77 to the HSD3B2 Promoter In Vitro and Reverses Endocrine and Metabolic Abnormalities in a Rat Model of Polycystic Ovary Syndrome","volume":"157","author":"Lee","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2024.109489_b0215","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/dna.2015.3145","article-title":"Differential Expression of microRNAs in the Ovaries from Letrozole-Induced Rat Model of Polycystic Ovary Syndrome","volume":"35","author":"Li","year":"2016","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.steroids.2024.109489_b0220","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1210\/en.2012-1693","article-title":"Continuous Administration of a P450 Aromatase Inhibitor Induces Polycystic Ovary Syndrome with a Metabolic and Endocrine Phenotype in Female Rats at Adult Age","volume":"154","author":"Maliqueo","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2024.109489_b0225","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1507\/endocrj.EJ16-0282","article-title":"Kisspeptin mRNA expression is increased in the posterior hypothalamus in the rat model of polycystic ovary syndrome","volume":"64","author":"Matsuzaki","year":"2017","journal-title":"Endocr. J."},{"key":"10.1016\/j.steroids.2024.109489_b0230","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3389\/fphar.2018.01325","article-title":"Therapeutic Effect of Ecklonia cava Extract in Letrozole-Induced Polycystic Ovary Syndrome Rats","volume":"9","author":"Yang","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.steroids.2024.109489_b0235","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.fertnstert.2005.06.013","article-title":"Persistent estrus rat models of polycystic ovary disease: An update","volume":"84","author":"Singh","year":"2005","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.steroids.2024.109489_b0240","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000123964","article-title":"Influence of Continuous Illumination on Estrous Cycle of Rats: Time Course of Changes in Levels of Gonadotropins and Ovarian Steroids until Occurrence of Persistent Estrus","volume":"39","author":"Takeo","year":"1984","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.steroids.2024.109489_b0245","first-page":"1","article-title":"Manifestation of Hyperandrogenism in the Continuous Light Exposure-Induced PCOS Rat Model","volume":"2015","author":"Kang","year":"2015","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.steroids.2024.109489_b0250","first-page":"747","article-title":"Proposal of an experimental model for the study of polycystic ovaries","volume":"24","author":"Baldissera","year":"1991","journal-title":"Braz. J. Med. Biol. Res. Rev. Bras. Pesqui. M\u00e9dicas E Biol\u00f3gicas Soc. Bras. Biof\u00edsica Al"},{"key":"10.1016\/j.steroids.2024.109489_b0255","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1096\/fj.12-210898","article-title":"Detrimental effects of constant light exposure and high-fat diet on circadian energy metabolism and insulin sensitivity","volume":"27","author":"Coomans","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.steroids.2024.109489_b0260","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1152\/ajplegacy.1966.210.5.1112","article-title":"Effect of light on corticosterone levels in plasma of rats","volume":"210","author":"Scheving","year":"1966","journal-title":"Am. J. Physiol.-Leg. Content"},{"key":"10.1016\/j.steroids.2024.109489_b0265","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1210\/en.2007-1254","article-title":"Locus Coeruleus Mediates Cold Stress-Induced Polycystic Ovary in Rats","volume":"149","author":"Bernuci","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2024.109489_b0270","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/asj.12762","article-title":"Effect of supplements during the cold season on the reproductive system in prepubertal Tibetan sheep ewes","volume":"88","author":"Jing","year":"2017","journal-title":"Anim. Sci. J."},{"key":"10.1016\/j.steroids.2024.109489_b0275","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s12576-015-0371-x","article-title":"Effect of menstrual cycle on thermal perception and autonomic thermoregulatory responses during mild cold exposure","volume":"65","author":"Matsuda-Nakamura","year":"2015","journal-title":"J. Physiol. Sci."},{"key":"10.1016\/j.steroids.2024.109489_b0280","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12958-020-00584-1","article-title":"Effect of cold stress on ovarian & uterine microcirculation in rats and the role of endothelin system","volume":"18","author":"Wang","year":"2020","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.steroids.2024.109489_b0285","first-page":"1","article-title":"Impact of Cold Exposure on the Reproductive Function in Female Rats","volume":"2018","author":"Xu","year":"2018","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.steroids.2024.109489_b0290","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2826.2012.02373.x","article-title":"Transitory Activation of the Central and Ovarian Norepinephrine Systems During Cold Stress-Induced Polycystic Ovary in Rats","volume":"25","author":"Bernuci","year":"2013","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.steroids.2024.109489_b0295","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1095\/biolreprod.116.142786","article-title":"High-fat high-sugar diet induces polycystic ovary syndrome in a rodent model\u2020","volume":"96","author":"Roberts","year":"2017","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.steroids.2024.109489_b0300","doi-asserted-by":"crossref","DOI":"10.1095\/biolreprod.114.120063","article-title":"High-Fat Diet Induces Significant Metabolic Disorders in a Mouse Model of Polycystic Ovary Syndrome1","volume":"91","author":"Lai","year":"2014","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.steroids.2024.109489_b0305","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1210\/js.2017-00305","article-title":"High-Fat, High-Sugar Diet Disrupts the Preovulatory Hormone Surge and Induces Cystic Ovaries in Cycling Female Rats","volume":"1","author":"Volk","year":"2017","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.steroids.2024.109489_b0310","doi-asserted-by":"crossref","first-page":"600","DOI":"10.25122\/jml-2021-0153","article-title":"Leptin hormone and its effectiveness in reproduction, metabolism, immunity, diabetes, hopes and ambitions","volume":"14","author":"Akeel Al-hussaniy","year":"2021","journal-title":"J. Med Life"},{"key":"10.1016\/j.steroids.2024.109489_b0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/132908","article-title":"Serum Leptin Levels in Polycystic Ovary Syndrome and Its Relationship with Metabolic and Hormonal Profile in Pakistani Females","volume":"2014","author":"Baig","year":"2014","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.steroids.2024.109489_b0320","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1095\/biolreprod.104.027292","article-title":"Folliculogenesis Is Impaired and Granulosa Cell Apoptosis Is Increased in Leptin-Deficient Mice1","volume":"71","author":"Hamm","year":"2004","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.steroids.2024.109489_b0325","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1757-2215-4-8","article-title":"Metformin therapy in a hyperandrogenic anovulatory mutant murine model with polycystic ovarian syndrome characteristics improves oocyte maturity during superovulation","volume":"4","author":"Sabatini","year":"2011","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.steroids.2024.109489_b0330","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/jrf.0.0640363","article-title":"Investigation into the hypogonadism of the obese mouse (genotype ob\/ob)","volume":"64","author":"Batt","year":"1982","journal-title":"Reproduction"},{"key":"10.1016\/j.steroids.2024.109489_b0335","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1210\/en.2008-1612","article-title":"A Unique Rodent Model of Cardiometabolic Risk Associated with the Metabolic Syndrome and Polycystic Ovary Syndrome","volume":"150","author":"Shi","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2024.109489_b0340","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2016.00044","article-title":"Mechanisms of Comorbidities Associated With the Metabolic Syndrome: Insights from the JCR:LA-cp Corpulent Rat Strain","volume":"3","author":"Diane","year":"2016","journal-title":"Front. Nutr."},{"key":"10.1016\/j.steroids.2024.109489_b0345","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1530\/JOE-11-0022","article-title":"The New Zealand obese mouse model of obesity insulin resistance and poor breeding performance: evaluation of ovarian structure and function","volume":"209","author":"Radavelli-Bagatini","year":"2011","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.steroids.2024.109489_b0350","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1365-2362.2000.00611.x","article-title":"Joost, A metabolic syndrome of hypertension, hyperinsulinaemia and hypercholesterolaemia in the New Zealand obese mouse","volume":"30","author":"Ortlepp","year":"2000","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.steroids.2024.109489_b0355","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1210\/endo.141.7.7578","article-title":"An Age-Related Ovarian Phenotype in Mice with Targeted Disruption of the Cyp 19 (Aromatase) Gene*","volume":"141","author":"Britt","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2024.109489_b0360","doi-asserted-by":"crossref","first-page":"6965","DOI":"10.1073\/pnas.95.12.6965","article-title":"Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene","volume":"95","author":"Fisher","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.steroids.2024.109489_b0365","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1677\/joe.0.1700099","article-title":"Targeted disruption of the aromatase P450 gene (Cyp19) in mice and their ovarian and uterine responses to 17beta-oestradiol","volume":"170","author":"Toda","year":"2001","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.steroids.2024.109489_b0370","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1210\/me.2002-0398","article-title":"Characterization of the Hypothalamic-Pituitary-Gonadal Axis in Estrogen Receptor (ER) Null Mice Reveals Hypergonadism and Endocrine Sex Reversal in Females Lacking ER\u03b1 But Not ER\u03b2","volume":"17","author":"Couse","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.steroids.2024.109489_b0375","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.mce.2004.10.013","article-title":"Multiple sites of tumorigenesis in transgenic mice overproducing hCG","volume":"234","author":"Huhtaniemi","year":"2005","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.steroids.2024.109489_b0380","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1210\/en.2002-220490","article-title":"Reproductive Disturbances, Pituitary Lactotrope Adenomas, and Mammary Gland Tumors in Transgenic Female Mice Producing High Levels of Human Chorionic Gonadotropin","volume":"143","author":"Rulli","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2024.109489_b0385","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1095\/biolreprod.102.013953","article-title":"Overexpression of Human Chorionic Gonadotropin Causes Multiple Reproductive Defects in Transgenic Mice1","volume":"69","author":"Matzuk","year":"2003","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.steroids.2024.109489_b0390","doi-asserted-by":"crossref","unstructured":"S.B. Rulli, M. Poutanen, I.T. Huhtaniemi, Phenotypic characterization of transgenic mouse models overproducing hCG, in: 100 Years Hum. Chorionic Gonadotropin, Elsevier, 2020: pp. 181\u2013191. https:\/\/doi.org\/10.1016\/B978-0-12-820050-6.00016-3.","DOI":"10.1016\/B978-0-12-820050-6.00016-3"},{"key":"10.1016\/j.steroids.2024.109489_b0395","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cmet.2010.03.002","article-title":"Direct Insulin and Leptin Action on Pro-opiomelanocortin Neurons Is Required for Normal Glucose Homeostasis and Fertility","volume":"11","author":"Hill","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.steroids.2024.109489_b0400","doi-asserted-by":"crossref","first-page":"e48643","DOI":"10.1371\/journal.pone.0048643","article-title":"Adipocyte Dysfunction in a Mouse Model of Polycystic Ovary Syndrome (PCOS): Evidence of Adipocyte Hypertrophy and Tissue-Specific Inflammation","volume":"7","author":"Marino","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.steroids.2024.109489_b0405","doi-asserted-by":"crossref","first-page":"11582","DOI":"10.1523\/JNEUROSCI.5712-08.2009","article-title":"Enhanced Stat3 Activation in POMC Neurons Provokes Negative Feedback Inhibition of Leptin and InsulinSignaling in Obesity","volume":"29","author":"Ernst","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.steroids.2024.109489_b0410","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/cen.12003","article-title":"The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target?","volume":"77","author":"Lansdown","year":"2012","journal-title":"Clin. Endocrinol. (oxf.)"},{"key":"10.1016\/j.steroids.2024.109489_b0415","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1210\/en.2008-1575","article-title":"Excessive Ovarian Production of Nerve Growth Factor Facilitates Development of Cystic Ovarian Morphology in Mice and Is a Feature of Polycystic Ovarian Syndrome in Humans","volume":"150","author":"Dissen","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2024.109489_b0420","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1210\/en.2014-1368","article-title":"Excess of Nerve Growth Factor in the Ovary Causes a Polycystic Ovary-Like Syndrome in Mice, which Closely Resembles Both Reproductive and Metabolic Aspects of the Human Syndrome","volume":"155","author":"Wilson","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2024.109489_b0425","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1210\/endo.141.3.7395","article-title":"An Increased Intraovarian Synthesis of Nerve Growth Factor and Its Low Affinity Receptor Is a Principal Component of Steroid-Induced Polycystic Ovary in the Rat 1","volume":"141","author":"Lara","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2024.109489_b0430","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.repbio.2013.12.002","article-title":"Estrogen hormone physiology: Reproductive findings from estrogen receptor mutant mice","volume":"14","author":"Hamilton","year":"2014","journal-title":"Reprod. Biol."},{"key":"10.1016\/j.steroids.2024.109489_b0435","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.1210\/jc.2010-0603","article-title":"MUC1 as a Discriminator between Endometrium from Fertile and Infertile Patients with PCOS and Endometriosis","volume":"95","author":"Margarit","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.steroids.2024.109489_b0440","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJMoa1303611","article-title":"Delayed Puberty and Estrogen Resistance in a Woman with Estrogen Receptor \u03b1 Variant","volume":"369","author":"Quaynor","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.steroids.2024.109489_b0445","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1186\/bcr79","article-title":"Estrogen receptor transcription and transactivation Estrogen receptor knockout mice: what their phenotypes reveal about mechanisms of estrogen action","volume":"2","author":"Hewitt","year":"2000","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.steroids.2024.109489_b0450","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1210\/endo.140.6.6823","article-title":"Targeted Disruption of the Estrogen Receptor-\u03b1 Gene in Female Mice: Characterization of Ovarian Responses and Phenotype in the Adult*","volume":"140","author":"Schomberg","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2024.109489_b0455","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1472-6483(10)61634-3","article-title":"Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome?","volume":"9","author":"Orio","year":"2004","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.steroids.2024.109489_b0460","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.3390\/ijms18081651","article-title":"Role of Plasminogen Activator Inhibitor Type 1 in Pathologies of Female Reproductive Diseases","volume":"18","author":"Ye","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.steroids.2024.109489_b0465","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.thromres.2008.07.004","article-title":"Transgenic overexpression of a stable Plasminogen Activator Inhibitor-1 variant","volume":"123","author":"Fahim","year":"2009","journal-title":"Thromb. Res."},{"key":"10.1016\/j.steroids.2024.109489_b0470","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1677\/JME-06-0057","article-title":"Transgenic overexpression of plasminogen activator inhibitor-1 promotes the development of polycystic ovarian changes in female mice","volume":"39","author":"Devin","year":"2007","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.steroids.2024.109489_b0475","doi-asserted-by":"crossref","DOI":"10.1095\/biolreprod.111.097808","article-title":"Rodent Models for Human Polycystic Ovary Syndrome1","volume":"86","author":"Walters","year":"2012","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.steroids.2024.109489_b0480","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0140-6736(90)92765-A","article-title":"Hypersecretion of luteinising hormone, infertility, and miscarriage","volume":"336","author":"Regan","year":"1990","journal-title":"The Lancet"},{"key":"10.1016\/j.steroids.2024.109489_b0485","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1210\/endo.138.8.5313","article-title":"Elevated Luteinizing Hormone in Prepubertal Transgenic Mice Causes Hyperandrogenemia, Precocious Puberty, and Substantial Ovarian Pathology 1","volume":"138","author":"Risma","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2024.109489_b0490","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1073\/pnas.92.5.1322","article-title":"Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors","volume":"92","author":"Risma","year":"1995","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.steroids.2024.109489_b0495","doi-asserted-by":"crossref","first-page":"E812","DOI":"10.1152\/ajpendo.00367.2002","article-title":"Obesity in transgenic female mice with constitutively elevated luteinizing hormone secretion","volume":"285","author":"Kero","year":"2003","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"key":"10.1016\/j.steroids.2024.109489_b0500","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1530\/rep.1.00661","article-title":"What have gonadotrophin overexpressing transgenic mice taught us about gonadal function?","volume":"130","author":"Rulli","year":"2005","journal-title":"Reproduction"},{"key":"10.1016\/j.steroids.2024.109489_b0505","doi-asserted-by":"crossref","first-page":"14440","DOI":"10.1096\/fj.202001060R","article-title":"Excess of ovarian nerve growth factor impairs embryonic development and causes reproductive and metabolic dysfunction in adult female mice","volume":"34","author":"Manti","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.steroids.2024.109489_b0510","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2015.00152","article-title":"Genetic Models for the Study of Luteinizing Hormone Receptor Function","volume":"6","author":"Narayan","year":"2015","journal-title":"Front. Endocrinol."}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X24001272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X24001272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T16:32:58Z","timestamp":1725899578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X24001272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":102,"alternative-id":["S0039128X24001272"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2024.109489","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rodent models in polycystic ovarian syndrome: Dissecting reproductive and metabolic phenotypes for therapeutic advancements","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2024.109489","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109489"}}